{"title": "Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/top/health.xml", "value": "Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190327112702.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190327112702.htm", "summary": "A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/top/health.xml", "value": "A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis."}, "published": "Wed, 27 Mar 2019 11:27:02 EDT", "published_parsed": [2019, 3, 27, 15, 27, 2, 2, 86, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190327112702.htm", "guidislink": false}